Novartis
Novartis officials announce the latest developments
Published in Medicine and Law Weekly, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Novartis.
Report 1: Novartis has received a positive opinion supporting European Union regulatory approval for Lucentis (ranibizumab) as a new treatment option for patients with the "wet" form of age-related macular degeneration (AMD), the leading cause of severe vision loss in people over age 50 in the western world.
The Committee for Medicinal Products for Human Use (CHMP), which reviews drug applications for all 25 countries in the European Union as well as Iceland and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Behavior
Research from Creighton University, Department of Psychology provides new data on behavior - Life Sciences
Data on life sciences described by researchers at University of Ruhuna, Department of Forensic Medicine - Life Sciences
Data on life sciences reported by researchers at Catholic University, Institute of Legal Medicine - Life Sciences
Studies conducted at Victoria University on life sciences recently published - Life Sciences
Studies from College of New Jersey, Department of Philosophy reveal new findings on life sciences - Life Sciences Therapy
Data on life sciences therapy discussed by researchers at University of Virginia - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
